Korean J Gastroenterol.  2024 Feb;83(2):74-77. 10.4166/kjg.2024.010.

Hepatic Epithelioid Hemangioendothelioma

• Lee SH
• Lee TY
• Cheon YK

• KMID: 2553440
• DOI: http://doi.org/10.4166/kjg.2024.010

Figure

• 

  Fig. 1 Ultrasonography showed a 5 cm-sized round-shaped hypoechoic mass in segment 2 of liver. (A) Sagittal scan. (B) Transverse scan.

• 

  Fig. 2 CT scan demonstrated a 5.3 cm-sized round-shaped hypodense mass with peripheral enhancement in the portal phase, accompanying with several daughter nodules (white arrowheads).

• 

  Fig. 3 MRI showed a 5.6 cm-sized heterogenous round-shaped mass, where relatively high signal intensity in T2-wieghted images (A) and low signal intensity with peripheral enhancement in T1-weighted images (B).

• 

  Fig. 4 The PET-CT scan revealed a hypermetabolic mass lesion with central necrosis in the left lobe of the liver, as well as several hypermetabolic daughter nodules and metastatic lymph nodes in the left gastric area (white arrowhead).

• 

  Fig. 5 Histologic examination (H&E staining x200) reveals that epithelioid malignant cells arranged in cords in myxoid stroma, and epithelioid cells show atypical nuclei with prominent nucleoli (inlet, black arrowhead).

Reference

1. Sardaro A, Bardoscia L, Petruzzelli MF, Portaluri M. 2014; Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor. Oncol Rev. 8:259. DOI: 10.4081/oncol.2014.259. PMID: 25992243. PMCID: PMC4419652.

2. Mehrabi A, Kashfi A, Fonouni H, et al. 2006; Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer. 107:2108–2121. DOI: 10.1002/cncr.22225. PMID: 17019735.

3. Läuffer JM, Zimmermann A, Krähenbühl L, Triller J, Baer HU. 1996; Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor. Cancer. 78:2318–2327. DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2318::AID-CNCR8>3.0.CO;2-I.

4. Deyrup AT, Tighiouart M, Montag AG, Weiss SW. 2008; Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 32:924–927. DOI: 10.1097/PAS.0b013e31815bf8e6. PMID: 18551749.

5. Salech F, Valderrama S, Nervi B, et al. 2011; Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol. 10:99–102. DOI: 10.1016/S1665-2681(19)31596-0. PMID: 21301019.

6. Grenader T, Vernea F, Reinus C, Gabizon A. 2011; Malignant epithelioid hemangioendothelioma of the liver successfully treated with pegylated liposomal doxorubicin. J Clin Oncol. 29:e722–e724. DOI: 10.1200/JCO.2011.35.5891. PMID: 21788568.

7. Wang LR, Zhou JM, Zhao YM, et al. 2012; Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients. World J Surg. 36:2677–2683. DOI: 10.1007/s00268-012-1714-x. PMID: 22890877.